These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26721305)

  • 41. S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison With Novel and Traditional Urothelial Immunohistochemical Markers.
    Suryavanshi M; Sanz-Ortega J; Sirohi D; Divatia MK; Ohe C; Zampini C; Luthringer D; Smith SC; Amin MB
    Adv Anat Pathol; 2017 May; 24(3):151-160. PubMed ID: 28398953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymphoepithelioma-like carcinoma of the urinary bladder: A case report.
    Laforga JB; Gasent JM
    Rev Esp Patol; 2017; 50(1):54-57. PubMed ID: 29179966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unexpected urothelial tumor in a young boy with asymptomatic hematuria.
    Ceccarelli PL; Caponcelli E; DI Pietro C; Biondini D; Bagni I; Cacciari A
    Minerva Pediatr; 2016 Oct; 68(5):385-7. PubMed ID: 27467106
    [No Abstract]   [Full Text] [Related]  

  • 44. Urothelial Carcinoma with shadow cell, lipid cell and sebaceous (skin adnexal) differentiation: Clinicopathological and immunohistochemical study of 10 cases.
    Behzatoğlu K
    Ann Diagn Pathol; 2015 Oct; 19(5):314-9. PubMed ID: 26235883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 Update.
    Cox RM; Magi-Galluzzi C; McKenney JK
    Adv Anat Pathol; 2018 Nov; 25(6):387-399. PubMed ID: 30157041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors in urothelial carcinoma of the bladder: histologic and molecular correlates.
    Solomon JP; Hansel DE
    Adv Anat Pathol; 2015 Mar; 22(2):102-12. PubMed ID: 25664945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel markers of squamous differentiation in the urinary bladder.
    Huang W; Williamson SR; Rao Q; Lopez-Beltran A; Montironi R; Eble JN; Grignon DJ; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Hahn NM; Wang M; Koch MO; Cheng L
    Hum Pathol; 2013 Oct; 44(10):1989-97. PubMed ID: 23806524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladder.
    Adam RM; DeGraff DJ
    Urol Oncol; 2015 Oct; 33(10):444-50. PubMed ID: 26254697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder.
    Dohn LH; Illemann M; Høyer-Hansen G; Christensen IJ; Hostmark J; Litlekalsoy J; von der Maase H; Pappot H; Laerum OD
    Urol Oncol; 2015 Apr; 33(4):165.e15-24. PubMed ID: 25575713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Histological variants of urothelial carcinoma with diagnostic, prognostic and therapeutical implications].
    Picazo ML; Regojo RM; González-Peramato P
    Actas Urol Esp; 2007 Oct; 31(9):989-1001. PubMed ID: 18257368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bladder tumor histo-seminar - case 6: Invasive urothelial carcinoma, with inverted growth (UroA/FGFR3 molecular type)].
    Allory Y
    Ann Pathol; 2016 Dec; 36(6):394-397. PubMed ID: 27838079
    [No Abstract]   [Full Text] [Related]  

  • 53. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Primary signet-ring cell bladder adenocarcinoma].
    Blasco Casares FJ; Saladié Roig JM; Ibarz Servio L
    Arch Esp Urol; 1991; 44(6):753-5. PubMed ID: 1663328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasmacytoid urothelial carcinoma of the urinary bladder: a case report and immunohistochemical study.
    Sato K; Ueda Y; Kawamura K; Aihara K; Katsuda S
    Pathol Res Pract; 2009; 205(3):189-94. PubMed ID: 19041193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cutaneous invasion from sarcomatoid urothelial carcinoma: clinical and dermatopathologic features.
    Bernardes Filho F; de Melo AS; Pires AR; Lupi O; das Neves DG; da Cruz MF; Kac BK
    An Bras Dermatol; 2016; 91(1):73-9. PubMed ID: 26982782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urothelial carcinoma of urinary bladder with exclusive heterologous component of epithelioid rhabdomyosarcoma at metastatic site.
    Agarwal P; Pasricha S; Gupta G; Sharma A; Mehta A
    Indian J Pathol Microbiol; 2018; 61(2):258-260. PubMed ID: 29676372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bladder tumor histoseminar - Case 2: Invasive urothelial carcinoma, with lamina propria invasion and micropapillary component].
    Sibony M
    Ann Pathol; 2016 Dec; 36(6):379-381. PubMed ID: 27838077
    [No Abstract]   [Full Text] [Related]  

  • 59. [Carcinoembryonic antigen in tumor tissue and urine in cases with primary bladder cancer--a study by immunogold-silver staining and radioimmunoassay].
    Kawano S
    Nihon Hinyokika Gakkai Zasshi; 1988 Mar; 79(3):469-74. PubMed ID: 2464713
    [No Abstract]   [Full Text] [Related]  

  • 60. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
    Shanks JH; Iczkowski KA
    Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.